Domov › Intersticijske pljučne bolezni › Florida
Klinične študije za Intersticijske pljučne bolezni v Florida
24 študij za Intersticijske pljučne bolezni išče udeležence na lokacijah v Florida.
Mesta v Florida
- Orlando9 študij
- Tampa8 študij
- Naples5 študij
- Gainesville5 študij
- Jacksonville5 študij
- Davie4 študij
- Miami4 študij
Uradno besedilo študije (angleško)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Clinical Research Specialists LLC - Kissimmee, Kissimmee
- Lakeland Regional Medical Center - Lakeland, Lakeland
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- in še 4
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Clinical Research Specialists LLC - Kissimmee, Kissimmee
Vključevanje udeležencevFaza 3
Starost 40 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA017, Gainesville
- USA006, Naples
- USA026, St. Petersburg
- in še 1
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- New Access Research and Medical Services, Miami
- Eunix Clinical Research, Orlando
- in še 1
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT05798923A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Kissimmee
Vključevanje udeležencevFaza 3
Starost 18–85 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07816185A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Gainesville
- GSK Investigational Site, Naples
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06572384A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Jacksonville
- GSK Investigational Site, Miami
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Cleveland Clinic Florida, Weston
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- AdventHealth Orlando, Orlando
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Tampa General Hospital, Tampa
Vključevanje udeležencevFaza 3
Starost 18–80 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kissimmee
Vključevanje udeležencevFaza 2
Starost 18–85 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- NCH Research Institute, Naples
- Advent Health Medical Group Advanced Lung Disease, Orlando
- in še 3
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT06388421Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
- University of Miami Hospital and Clinics, Miami
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07486869RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Florida, Jacksonville
Vključevanje udeležencevFaza 2/3
Starost 18–75 · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT06328777An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA006, Naples
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 13. avg. 2026 · NCT07234032Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Florida, Gainesville
- University of South Florida, Tampa
Vključevanje udeležencevOpazovalna študija
Starost 21 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Mayo Clinic of Florida, Jacksonville
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07175038Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- University of South Florida, Tampa
Vključevanje udeležencevFaza 2
Starost 4 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Ascension Medical Group St. Vincent's Lung Institute, Jacksonville
- Mayo Clinic, Jacksonville
- TGH/USF Center for Advanced Lung Disease and Lung Transplant, Tampa
- in še 1
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 13. jul. 2026 · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Advent Health, Orlando
- Tampa General Hospital Center of Research Excellence, Tampa
Vključevanje udeležencevOpazovalna študija
Starost 18–80 · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT06129240Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
- Mayo Clinic in Florida, Jacksonville
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 20. mar. 2026 · NCT06751069Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
- Maule Stem Cell Research Institute, Venice
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 29. jan. 2026 · NCT07372989Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Florida Lung Asthma and Sleep Specialist, Celebration
- Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 12. nov. 2025 · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Miami
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 7. maj 2025 · NCT05892614Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.